Drug Product Leadership Group

The mission of the IQ DPLG is to influence the strategic direction of drug product development and manufacturing for the benefit of industry and patients. The DPLG seeks to proactively implement strategies to address critical issues; interact with regulatory and professional organizations to improve processes and guidance; build relationships within IQ to exchange information and find solutions to CMC issues that enable innovation; and publicly share information to encourage alignment across the pharmaceutical CMC community.

The Drug Product Leadership Group is focusing on understanding, through surveys and dialogue, industry practices related to development and manufacturing. Through sponsorship or participation, DPLG has been involved in a variety of Working Groups. Presently, it is active in the following: Pediatric Formulation Development, Novel Excipients and Continuous Manufacturing.

The DPLG and its Working Groups plan to develop and implement strategies to address critical challenges, and share the results of their work.